vaccine

PFE Stock Price Pullback Represents a Buying Opportunity

PFE Stock Price Pullback Represents a Buying Opportunity

Shares of Pfizer (PFE) are down 20% from their early December 52-week peak at $43.08 and have been hovering around their 200-day moving average for seven-straight sessions. There is still risk towards the $34.25 down to $34 area on continued weakness with the recent low tapping $34.27 earlier this month. There are a number of […]

Trade of the Week: Pfizer

Trade of the Week: Pfizer

Pfizer (PFE) has been a hot stock this year as it is the first company to get a Covid-19 vaccine to the market. While a vaccine isn’t going to make or break a pharmaceutical giant like PFE, it certainly isn’t going to hurt the bottom line either. PFE stock has had a decent year so […]

Vaccine in vial with syringe

Is Palantir the Next Big Thing in the Tech Sector?

Although the U.S. elections are garnering most of the media attention, the bigger deal for investors is the potential success of a coronavirus vaccine. The Pfizer (PFE) and BioNTech (BNTX) vaccine, with its 90% success rate in trials, could be a significant game changer for a world desperately seeking to find its way out of […]

Genetic Code Sequence of DNA Protein Art

How Big an Investment Opportunity Are Vaccines?

There was great news this week about the novel coronavirus vaccine being developed by Pfizer (PFE) and Germany‚Äôs BioNTech (BNTX). The vaccine has been found to be more than 90% effective, and, if approved, it will be the first vaccine ever that uses novel mRNA technology. These results (although early and not independently vetted) far […]